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In vivo evaluation of Monascus-fermented durian seed for antidiabetic 
and antihypercholesterol agent 
Abstract
Monascus-fermented durian seed (MFDS) had been developed previously. This research 
was aimed to evaluate the MFDS for antidiabetic and antihypercholesterol agent with in vivo 
method using Wistar rat. The MFDS was produced by inoculating the spore suspension of 
Monascus sp. KJR2 into durian seed cuts and then incubated at room temperature (30°C) for 14 
days. The product was dried and ground to produce MFDS powder. The MFDS suspension was 
evaluated its lowering blood glucose and cholesterol concentration in vivo using male Wistar 
rats. Administration of 2 mL of product suspensions at the level of 0.05; 0.10; and 0.15 g/2 mL 
for 28 days decreased 12.89% of blood glucose and 49.3% serum cholesterol concentration in 
the rats. Higher level of MFDS suspension resulting higher effectiveness of the lowering blood 
glucose and total cholesterol. MFDS also improved lipid profile including HDL-cholesterol, 
LDL-cholesterol and Triglyceride levels.
1.  Introduction
Monascus-fermented product, especially 
Monascus-fermented rice has been used by Asian 
people for centuries as natural food colorant, food 
supplement and traditional medicine. During solid 
state fermentation, Monascus produces various 
secondary metabolites primarily pigments and 
monacolines with various bioactivities, and the 
fermented products showed possitive health effects 
(Chang et al., 2006; Chen et al., 2006; Lin et al., 
2008; Shi et al., 2010; Shi et al., 2012).
Monascus-fermented durian seed is a 
fermentation product of Monascus on durian seed 
as the substrate. Our previous finding showed that 
the Monascus-Fermented Durian Seeds (MFDS) 
contain pigments (yellow, orange and red pigments), 
monacolin K and phenolic (Srianta, Novita and 
Kusumawati, 2012; Srianta et al., 2012). Some 
researchers also reported that Monascus-fermented 
products contain monacolin K (Chairote et al., 
2008).  In vitro antidiabetic assay i.e. α-glucosidase 
inhibition activity of MFDS extract showed that the 
MFDS potent to be developed as antidiabetic product 
(Srianta et al., 2013). Monacolin K posses lowering 
blood cholesterol effect through inhibition of 
HMGCoA reductase activity, enzyme in cholesterol 
biosynthesis pathway (Endo, 1980; Endo, 1988). Li et 
al. (1998) reported the antihypercholesterol activity 
of Monascus-fermented rice. However, evaluation of 
antidiabetic and antihypercholesterol of MFDS have 
not been studied yet. Objective of this research was to 
evaluate in vivo antidiabetic and antihypercholesterol 
activities of MFDS.
2.   Materials and methods
2.1 MFDS production
Durian seeds were boiled in a CaCO3 solution 
of 5% w/v for 10 min to remove the mucus. After 
the seed coat were peeled off, the seeds were cut 
into small size. A 50 g of small cut durian seed was 
transferred into 300 mL flask, mixed thoroughly, 
autoclaved at 121°C for 15 min, then left to cool 
at room temperature, inoculated with the spore 
suspension of Monascus sp. KJR2 and incubated 
at room temperature (30°C) for 14 days in static 
conditions (with manual shaking daily). Monascus-
fermented durian seed were dried in an oven at 45°C 
for 24 hours and ground. 
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2.2  In vivo evaluation of MFDS antidiabetic and 
antihypercholesterol activities
The committee of ethical clearance of the 
Integrated Research and Testing Laboratory Gadjah 
Mada University approved this in vivo experiment 
with ethical clearance number of 142/KEC-LPPT/
IV/2014. Animals were treated in accordance for the 
proper care and use of laboratory animals.
Twenty four (24) male Wistar rats about 2 months 
old (weight range of 250-300 g) were adapted for 
a week with feeding of standard feed (AIN-93M) 
(Table 1). At the end of the adaptation, blood glucose 
level and lipid profile (total cholesterol, HDL-
cholesterol, LDL-cholesterol, dan Triglyceride) of 
blood serum  were analyzed. After that, the rats were 
fed with high cholesterol feed for a week to make 
hypercholesterol rats, with total cholesterol of > 130 
mg/dL. The high cholesterol feed was formulated as 
standard feed with an addition of 1% of cholesterol 
(Matos et al., 2005). Then, the rats were induced to 
diabetic by injecting of streptozotocin (STZ) 65 mg/
kg and Nicotineamide (NA) 230 mg/kg body weight 
(Szkudelski, 2012). The rats were fed with standard 
feed for 5 days until the rats got diabetic (Marsono et 
al., 2003). During the diabetic induction, to prevent 
the rats of having hypoglycemic condition  they were 
given dextrose solution by forced feeding. 
Table 1. Composition of the diets (g/1000 g of diet)
Component Standard *, (g)
High 
Cholesterol**, 
(g)
Corn starch 620.692 610.692
Casein 140 140
Sucrose 100 100
Soybean oil 40 40
Cellulosa 50 50
Cholesterol - 10
Mineral mix 35 35
Vitamin mix 10 10
L-cystine 1.8 1.8
Cholin bitartrate 2.5 2.5
tert-butyl hydroquinone 
(TBHQ) 
0.008 0.008
Total 1000 1000
Source: *) Reeves et al. (1993)
           **) Hypercholesterolemic diets were suplemented  
                  with 10 g of   cholesterol per kg of diet, at the 
                  expense of starch.
The rats were divided randomly into 4 groups 
of 6 rats i.e.: Control group fed with standard feed, 
and the other groups were fed with standard fed and 
given 2 mL of  0.05g MFDS suspension (MF0.05), 
0.10g MFDS suspension (MF0.10) and 0.15g MFDS 
suspension (MF0.15), respectively.
The feed and water were given ad libitum and 
MFDS suspension was administered by forced 
feeding daily for 28 days. The rats were weighed at 
the early of the experiment and every week during 
the experiment. Analysis of blood glucose and lipid 
profile were carried out every week, after 12 hours 
fasting. 
2.3 Data analysis
The obtained data were calculated for the 
average. The data obtained after 28 days treatment 
period were analyzed statistically using Analysis of 
varians with α = 5% and Least Significant Difference 
with α = 5%. 
3.   Results and discussion
A high cholesterol diet and streptozotocin injection 
resulted in hypercholesterol (total cholesterol of 
blood serum were 211 and 225 mg/dL) and diabetic 
(glucose levels of blood  serum were in a range of 
216 and 220 mg/dL) rats. Figure 1(a) showed that 
the body weight of all the rats with MFDS treatments 
increase, while the control tend to decrease during 
the experiment. Figure 1(b) showed that the control 
feeding intake higher than those of the treatments. 
This rats weight decreasing during experiment seem 
was due to the effect of diabetes on rats. Diabetic rats 
tend to polyuria, polydipsia, polyfagia, and loose body 
weight. In a research by Akbarzadeh et al. (2007), it 
was shown that consumed food in normal rats was 10 
± 2 grams, while in streptozotocin induced diabetic 
rats was 45 ± 5 grams, the water consumed by normal 
rats was around 35 ml, while in streptozotcin induced 
diabetic rats was 150 ml, and the volume of urine in 
normal rats was 10 ± 1 ml and in the streptozotocin 
induced diabetic rats was 130 ± 5 ml.
Figure 2 is blood glucose levels during the 
experiment. Streptozotocin destroyed the B cells of 
the pancreas by DNA alkylation, which led to B cell 
necrosis (Szkudelski, 2001). From the figure, it was 
concluded that the glucose level for all groups were 
normal, and then the treatment using streptozotocin 
was successful to increasing the glucose level up to 
a constant level at the end of the period of induction. 
Administration of MFDS suspension at the level 
of 0.05; 0.10; and 0.15 g/2 mL for 28 days showed 
lowering blood glucose level effect in the rats. Higher 
level of MFDS suspension, higher effectiveness 
in lowering blood glucose of the rats. Chang et al. 
(2006) found similar result that oral administration of 
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Figure 1. Rats body weight (a) and feed intake (b) during 
experiment. A (adaptation); I (induction); T0 (day 0 of treatment); 
T7 (7 days of treatment); T14 (14 days of treatment); T21 (21 
days of treatment); T28 (28 days of treatment).
Figure 2. Blood glucose levels (mg/dL) during experiment. A 
(adaptation); I (induction); T0 (day 0 of treatment); T7 (7 days 
of treatment); T14 (14 days of treatment); T21 (21 days of 
treatment); T28 (28 days of treatment).
Monascus-fermented rice at 50-350 mg/kg reduced 
plasma glucose of streptozotocin-diabetic rats. The 
decreasing plasma glucose was in a dose depedent 
manner. Shi and Pan (2010) also reported that feeding 
of different type of Monascus-fermented products 
i.e. Monascus-fermented rice, Monascus-fermented 
dioscorea and Monascus-fermented adlay reduced 
blood glucose levels of   diabetic rats after after 8 
weeks of feeding.
Those effects might be due to MFDS posses 
α-glucosidase inhibition activity, which related to 
the phenolic content of the product (Srianta et al., 
2013). Moreover, during fermentation on durian seed 
substrate, the Monascus purpureus produce yellow, 
orange and red pigments (Srianta et al., 2012). The 
pigments might be contribute to the antidiabetic 
activity. Lee et al. (2011) reported that yellow 
pigment, Monascin, was able to improve insulin 
sensitivity through serine/threonine protein kinases 
pathway by stabilizing PPAR-γ structure, preventing 
its phosphorylation, and inhibiting c-Jun N-terminal 
kinase activation. Shi et al. (2012) suggest that the 
Monascin has a therapeutic potential on diabetes and 
diabetes-associated oxidative stress complications. 
Higher level of MFDS suspension has higher contents 
of phenolic and pigments which might be resulted 
higher effectiveness in lowering blood glucose. In 
this experiment, blood glucose level of the MF0.1 
and MF0.15 group decreased by 5.76%, and 12.89% 
respectively when compared to those glucose levels 
after induction. The greatest effec of decrease in 
blood glucose level was achieved in 2 weeks after 
the treatment, followed by constant decrease until the 
end of experiment (1 month MFDS treatment). 
Figure 3. Blood cholesterol levels (mg/dL) during 28 days 
experiment. A (adaptation); I (induction); T0 (day 0 of treatment); 
T7 (7 days of treatment); T14 (14 days of treatment); T21 (21 
days of treatment); T28 (28 days of treatment).
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Total cholesterol levels during experiment is 
shown in Figure 3. High cholesterol feeding resulted 
high blood total cholesterol level in all groups of 
rats. All treatment was succesful to lowering the 
blood cholesterol levels during 28 days experiments. 
Higher level MFDS resulted lower total cholesterol 
level. Total cholesterol level of the MF0.15 group 
decreased 49.3%. Yeap et al. (2014) found similar 
results that administration of Monascus-fermented 
rice water extracts (MARDI Monascus-fermented 
rice and Commercial Monascus-fermented rice) at 60 
mg/kg reduced blood cholesterol levels signicantly.     
Table 2. Blood LDL-c, HDL-c and triglyceride levels 
(mg/dl) during 28 days experiment
Group
Period (week)
0 1 2 3 4
LDL-c level (mg/dL)
Control 100.3 102.86 103.35 102.42 103.2d
MF0.05 96.15 99.69 93.70 70.00 63.26c
MF0.10 95.24 99.29 98.48 57.58 51.15b
MF0.15 99.7 104.19 103.15 57.98 48.05a
HDL-c level (mg/dL)
Control 23.29 22.47 21.40 23.42 22.22a
MF0.05 28.38 27.31 29.55 39.94 47.48b
MF0.10 28.68 27.46 34.79 53.45 60.90c
MF0.15 25.91 24.82 34.50 61.93 70.56d
Triglyceride level (mg/dL)
Control 141.33 146.94 147.79 145.40 148.28c
MF0.05 135.90 142.05 131.20 100.30 93.12b
MF0.10 133.64 140.06 120.85 84.01 79.37a
MF0.15 139.22 145.57 127.70 80.09 74.44a
Note: different character in the same column indicated a 
significantly different at α = 5%
Table 2 is blood LDL-c, HDL-c and triglyceride 
levels data during the experiment. HDL-c (“good 
cholesterol”) and LDL-c (“bad cholesterol”) are the 
forms of cholesterol circulated in the blood. HDL is 
called good cholesterol as it has little cholesterol and 
high in protein content, while LDL is the opposite 
way. LDL is the source of artery clogging plaque, 
while HDL actually works to clear cholesterol from 
the blood (Ma, 2006).
As seen in Table 2, HDL in the MF0.15 
group was highest, while the LDL level was the 
lowest. Triglycerides are another form of fat in the 
bloodstream. High level of triglycerides indicated 
high risk of cardiac disease. A high triglycerides level 
with high LDL level or lower HDL level increases 
the speed of atheroschlerosis, which increases the 
risk of heart attack and stroke (Ma, 2006). In this 
experiment, triglycerides of the MF.015 group 
decreased by 54.88% from the hypercholesterol 
level, the highest decrement compared to the other 
treatment level, while the control group triglycerides 
level increased by 5.46%. 
It is concluded that MFDS improved lipid 
profile including lowering total cholesterol, LDL-
cholesterol, triglyceride and increasing HDL-
cholesterol. Yeap et al. (2014) found similar results 
that administration of Monascus-fermented rice 
water extracts (MARDI Monascus-fermented rice 
and Commercial Monascus-fermented rice) at 60 mg/
kg decreased blood cholesterol, triglyceride, LDL-
cholesterol levels and increase HDL-cholesterol 
significantly.
The mechanism was might be due to combination 
effect of bioactive compounds in the MFDS. 
The MFDS  contain monacolin K and pigments 
(Srianta et al., 2012). Monacolin K is well known 
cholesterol lowering agent and it has been used 
for hypercholesterol drug widely. Its action is to 
inhibit HMG-CoA reductase, the first enzyme in 
cholesterol biosynthesis pathway, activity. Jou et 
al. (2010) reported that monascus yellow pigments, 
Monascin and Ankaflavin, might reduce triglyceride 
accumulation and suppress expression of adipocyte-
specific transcription factors to decrease proliferation 
and differentiation of preadipocyte. Both of them 
might also promote mature adipocyte delipidation by 
releasing glycerol and downregulating the HR-LPL 
activities. According to Li et al. (1998), Monascus-
fermented product contain not only inhibitors of 
HMG-CoA reductase, but also monosaturated fatty 
acids, sterols, proteins, saccharide, isoflavone and 
its glycoside, saponin and sapogenin, and trace 
elements such as selenium and zinc. They suggest 
that combination of its total constituents might effect 
on the improving cholesterol status. However, the 
precise contribution need further study. 
Drugs lowering cholesterol are clofibrate, 
gemfibrozil, nicotinic acid (niacin), resin, statin, bile 
acid sequestrants and fibrates. MFDS was similar 
to statin as it lowers the LDL and triglyceride and 
has mild effect in increasing HDL (Yee et al., 2004; 
Zhang et al., 2008). Statins blocks the production of 
cholesterol in the liver itself (Ma, 2006). However, 
there are side effects of these drugs, such as muscle 
aches, abnormal liver function, allergic reaction 
(skin rashes), heartburn, dizziness, abdominal pain, 
constipation and decreased sexual desire) (Ma, 
2006). In this experiment, side effects of MFDS both 
in physical form and in molecular form  in short and 
long term was not observed yet. 
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Conclusion
Administration of MFDS suspension at the level 
of 0.05; 0.10; and 0.15 g/2 mL for 28 days showed 
lowering blood glucose and cholesterol effect. Higher 
level of MFDS suspension, higher effectiveness 
in lowering blood glucose and cholesterol levels 
of the rats. Moreover the treatments also improved 
blood lipid profile including HDL cholesterol, LDL 
cholesterol and triglyceride levels. Further study on 
side effects of MFDS need to be carried out.    
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